NBTX
Price
$3.31
Change
-$0.08 (-2.36%)
Updated
May 1, 04:53 PM (EDT)
Capitalization
159.7M
13 days until earnings call
PBYI
Price
$3.08
Change
-$0.10 (-3.14%)
Updated
May 1, 04:59 PM (EDT)
Capitalization
152.8M
7 days until earnings call
Ad is loading...

NBTX vs PBYI

Header iconNBTX vs PBYI Comparison
Open Charts NBTX vs PBYIBanner chart's image
Nanobiotix SA
Price$3.31
Change-$0.08 (-2.36%)
Volume$159
Capitalization159.7M
Puma Biotechnology
Price$3.08
Change-$0.10 (-3.14%)
Volume$3.41K
Capitalization152.8M
NBTX vs PBYI Comparison Chart
Loading...
NBTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBYI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NBTX vs. PBYI commentary
May 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBTX is a Buy and PBYI is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 02, 2025
Stock price -- (NBTX: $3.39 vs. PBYI: $3.18)
Brand notoriety: NBTX and PBYI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NBTX: 156% vs. PBYI: 136%
Market capitalization -- NBTX: $159.7M vs. PBYI: $152.8M
NBTX [@Biotechnology] is valued at $159.7M. PBYI’s [@Biotechnology] market capitalization is $152.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NBTX’s FA Score shows that 0 FA rating(s) are green whilePBYI’s FA Score has 1 green FA rating(s).

  • NBTX’s FA Score: 0 green, 5 red.
  • PBYI’s FA Score: 1 green, 4 red.
According to our system of comparison, PBYI is a better buy in the long-term than NBTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NBTX’s TA Score shows that 3 TA indicator(s) are bullish while PBYI’s TA Score has 4 bullish TA indicator(s).

  • NBTX’s TA Score: 3 bullish, 6 bearish.
  • PBYI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PBYI is a better buy in the short-term than NBTX.

Price Growth

NBTX (@Biotechnology) experienced а +2.91% price change this week, while PBYI (@Biotechnology) price change was +4.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.98%. For the same industry, the average monthly price growth was +8.35%, and the average quarterly price growth was -7.74%.

Reported Earning Dates

NBTX is expected to report earnings on Sep 04, 2025.

PBYI is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+2.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBTX($160M) and PBYI($153M) have the same market capitalization . NBTX YTD gains are higher at: 18.118 vs. PBYI (4.262).
NBTXPBYINBTX / PBYI
Capitalization160M153M105%
EBITDAN/A48.1M-
Gain YTD18.1184.262425%
P/E RatioN/A5.13-
RevenueN/A230M-
Total CashN/A101M-
Total DebtN/A74.1M-
FUNDAMENTALS RATINGS
PBYI: Fundamental Ratings
PBYI
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
24
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NBTXPBYI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 11 days ago
78%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 11 days ago
85%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 11 days ago
86%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
86%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
86%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 21 days ago
73%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 24 days ago
84%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
82%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
NBTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBYI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFLGX10.75N/A
N/A
Hennessy Cornerstone Large Growth Inv
DRTHX17.59N/A
N/A
BNY Mellon Sustainable US Eq Fd Z
KAUFX5.31N/A
N/A
Federated Hermes Kaufmann R
JACLX16.58N/A
N/A
JHancock Mid Cap Growth C
PHPSX18.64N/A
N/A
ProFunds Pharmaceuticals UltraSector Svc

NBTX and

Correlation & Price change

A.I.dvisor tells us that NBTX and PBYI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBTX and PBYI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBTX
1D Price
Change %
NBTX100%
+7.66%
PBYI - NBTX
28%
Poorly correlated
+4.61%
GLMD - NBTX
26%
Poorly correlated
-5.11%
CRMD - NBTX
25%
Poorly correlated
+0.77%
IVF - NBTX
24%
Poorly correlated
+48.44%
GLPG - NBTX
24%
Poorly correlated
+0.15%
More

PBYI and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBYI has been loosely correlated with RGNX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PBYI jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBYI
1D Price
Change %
PBYI100%
+4.61%
RGNX - PBYI
37%
Loosely correlated
+2.07%
COGT - PBYI
35%
Loosely correlated
+3.98%
MDGL - PBYI
34%
Loosely correlated
-2.02%
AURA - PBYI
34%
Loosely correlated
+4.68%
RARE - PBYI
33%
Loosely correlated
+2.39%
More